Search Results - "Caskey, Marina"
-
1
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
Published in Nature medicine (01-04-2019)“…Combination anti-retroviral therapy (ART) has revolutionized the treatment and prevention of HIV-1 infection. Taken daily, ART prevents and suppresses the…”
Get full text
Journal Article -
2
Plasma Neutralization of the SARS-CoV-2 Omicron Variant
Published in The New England journal of medicine (10-02-2022)“…Neutralization assays of SARS-CoV-2 pseudoviruses expressing wild-type, omicron, or a synthetic resistant spike protein in plasma drawn from 47 people over…”
Get full text
Journal Article -
3
Evolution of antibody immunity to SARS-CoV-2
Published in Nature (London) (25-03-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected 78 million individuals and is responsible for over 1.7 million deaths to date…”
Get full text
Journal Article -
4
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Published in Nature (London) (22-04-2021)“…Here we report on the antibody and memory B cell responses of a cohort of 20 volunteers who received the Moderna (mRNA-1273) or Pfizer–BioNTech (BNT162b2)…”
Get full text
Journal Article -
5
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Published in The Journal of experimental medicine (02-11-2020)“…The emergence of SARS-CoV-2 and the ensuing explosive epidemic of COVID-19 disease has generated a need for assays to rapidly and conveniently measure the…”
Get full text
Journal Article -
6
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape
Published in Nature (London) (16-12-2021)“…The number and variability of the neutralizing epitopes targeted by polyclonal antibodies in individuals who are SARS-CoV-2 convalescent and vaccinated are key…”
Get full text
Journal Article -
7
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Published in Nature (London) (15-07-2021)“…More than one year after its inception, the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…”
Get full text
Journal Article -
8
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Published in Cell (20-08-2020)“…Neutralizing antibody responses to coronaviruses mainly target the receptor-binding domain (RBD) of the trimeric spike. Here, we characterized polyclonal…”
Get full text
Journal Article -
9
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Published in Nature communications (07-07-2021)“…Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions…”
Get full text
Journal Article -
10
Enhanced SARS-CoV-2 neutralization by dimeric IgA
Published in Science translational medicine (20-01-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), primarily infects cells at mucosal…”
Get more information
Journal Article -
11
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Published in eLife (28-10-2020)“…Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future protection of individuals and populations against…”
Get full text
Journal Article -
12
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
Published in Nature (London) (07-07-2022)“…The Omicron variant of SARS-CoV-2 infected many vaccinated and convalescent individuals 1 – 3 . Despite the reduced protection from infection, individuals who…”
Get full text
Journal Article -
13
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Published in Nature (London) (16-12-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B cell responses that continue to evolve for at least a year. During that time,…”
Get full text
Journal Article -
14
Persistent cellular immunity to SARS-CoV-2 infection
Published in The Journal of experimental medicine (05-04-2021)“…SARS-CoV-2 is responsible for an ongoing pandemic that has affected millions of individuals around the globe. To gain further understanding of the immune…”
Get full text
Journal Article -
15
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
Published in Immunity (Cambridge, Mass.) (10-08-2021)“…Antibodies elicited by infection accumulate somatic mutations in germinal centers that can increase affinity for cognate antigens. We analyzed 6 independent…”
Get full text
Journal Article -
16
Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Published in Science (American Association for the Advancement of Science) (20-05-2016)“…Antiretroviral drugs and antibodies limit HIV-1 infection by interfering with the viral life cycle. In addition, antibodies also have the potential to guide…”
Get full text
Journal Article -
17
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
Published in Nature medicine (01-11-2018)“…Monotherapy of HIV-1 infection with single antiretroviral agents is ineffective because error-prone HIV-1 replication leads to the production of drug-resistant…”
Get full text
Journal Article -
18
Circulating precursors of human CD1c+ and CD141+ dendritic cells
Published in The Journal of experimental medicine (09-03-2015)“…Two subsets of conventional dendritic cells (cDCs) with distinct cell surface markers and functions exist in mouse and human. The two subsets of cDCs are…”
Get full text
Journal Article -
19
HIV-1 Integration Landscape during Latent and Active Infection
Published in Cell (29-01-2015)“…The barrier to curing HIV-1 is thought to reside primarily in CD4+ T cells containing silent proviruses. To characterize these latently infected cells, we…”
Get full text
Journal Article -
20
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico
Published in Cell (04-05-2017)“…Antibodies to Zika virus (ZIKV) can be protective. To examine the antibody response in individuals who develop high titers of anti-ZIKV antibodies, we screened…”
Get full text
Journal Article